TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Nobel Biocare Norge AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
28,656
|
32,429
|
34,083 |
Financial expenses |
960
|
449
|
194 |
Earnings before taxes |
-665
|
126
|
1,484 |
Total assets |
30,381
|
29,940
|
30,125 |
Current assets |
11,715
|
11,420
|
11,699 |
Current liabilities |
22,105
|
21,145
|
21,422 |
Equity capital |
8,276
|
8,796
|
8,703 |
- share capital |
100
![]() |
100
![]() |
100 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.2%
|
29.4%
|
28.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.3%
|
0.4%
|
4.4% |
Return on assets (ROA) |
1.0%
|
1.9%
|
5.6% |
Current ratio |
53.0%
|
54.0%
|
54.6% |
Return on equity (ROE) |
-8.0%
|
1.4%
|
17.1% |
Change turnover |
-3,773
|
-1,654
|
6,910 |
Change turnover % |
-12%
|
-5%
|
25% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.